Coherus BioSciences (CHRS) Reports Q1 Loss Per Share of $1.22
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.37 +1.48%
Revenue Growth %: +37.8%
Financial Fact:
Depreciation and amortization: 14.21M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +37.8%
Financial Fact:
Depreciation and amortization: 14.21M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Microchip Technology completes acquisition of Hailo
- BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
